TORONTO, ONTARIO--(CCNMatthews - Nov. 30, 2006) - OccuLogix, Inc. (NASDAQ:OCCX)(TSX:OC) today announced that it has agreed to acquire 50.1% of the capital stock of San Diego, CA based OcuSense, Inc. An in vitro diagnostics company, OcuSense is developing technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
